Sort
51,593 grants matching “hepatitis”
Influence of Heme on Hepatic Cytochrome P450 Turnover
$556,654Maria Almira Correia · University Of California, San Francisco · R01 · FY2016 · DK
Regulation of lipid metabolism in pulmonary Type 2 cells
$556,622Itsaso Garcia-Arcos · Suny Downstate Medical Center · R01 · FY2024 · HL
Project 1: Post-Shock Mesenteric Lymph and the 5-Lipoxygenase Pathway
$556,604Ernest E Moore · University Of Colorado Denver · P50 · FY2012 · GM
Epigenomics of Air Pollution driven Inflammation, Obesity and Insulin Resistance
$556,576Shyam Biswal · Johns Hopkins University · U01 · FY2016 · ES
Mechanism of Viral RNA-dependent RNA Synthesis
$556,529C. Cheng Kao · Texas A&M Research Foundation · · FY2003 · BIO
Trans-acting Factors Causing Cell Specific Gene Control
$556,526Kenneth S Zaret · Research Inst Of Fox Chase Can Ctr · R37 · FY2008 · GM
Development and Validation of a Novel and HIV-Relevant Prediction Model for Fracture
$556,513Evelyn Hsieh · Yale University · R01 · FY2025 · AR
Role of heat shock transcription factor HSF1 in tumoroginesis
$556,510Nahid F Mivechi · Augusta University · R01 · FY2017 · CA
Role of heat shock transcription factor HSF1 in tumoroginesis
$556,510Nahid F Mivechi · Augusta University · R01 · FY2018 · CA
Role of heat shock transcription factor HSF1 in tumoroginesis
$556,510Nahid F Mivechi · Augusta University · R01 · FY2016 · CA
Cross platform analysis of drug targets and toxicity of bath salts
$556,470Isaac T Schiefer · University Of Toledo Health Sci Campus · U01 · FY2024 · DA
Cross platform analysis of drug targets and toxicity of bath salts
$556,470Isaac T Schiefer · University Of Toledo Health Sci Campus · U01 · FY2025 · DA
Cross platform analysis of drug targets and toxicity of bath salts
$556,470Isaac T Schiefer · University Of Toledo Health Sci Campus · U01 · FY2023 · DA
Biobehavioral Studies of Obesity, Weight loss and Recidivism
$556,363Monica Skarulis · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK
Project 2: Targeting STAT3 with an Oral Small Molecule to Treat HCC
$556,316David John Tweardy · University Of Tx Md Anderson Can Ctr · P50 · FY2021 · CA
Lipoprotein(a) and Atherosclerosis
$556,312Robert E Pitas · J. David Gladstone Institutes · R01 · FY2007 · HL
Statistical Methods for Complex HIV Cohort Studies
$556,277University Of California San Francisco · R01 · FY2003 · AI
Biology of REV-ERB nuclear receptors
$556,221Mitchell A. Lazar · University Of Pennsylvania · R01 · FY2024 · DK
Prevention of Pediatric NAFLD in Hispanic Children
$556,199Miriam B. Vos · Emory University · R01 · FY2024 · NR
Quantitative Multimodal Imaging Biomarkers for Combined Locoregional and Immunotherapy of Liver Cancer
$556,171James S Duncan · Yale University · R01 · FY2024 · CA
Structure and function of the HCV replication complex
$556,166Anna Marie Pyle · Yale University · R01 · FY2013 · AI
Varenicline for the treatment of cocaine dependence: Phase II
$556,118Kyle Matthew Kampman · University Of Pennsylvania · U01 · FY2016 · DA
Durable Schistosome induced metabolic alterations to the myeloid lineage
$556,037Keke Celeste Fairfax · University Of Utah · R01 · FY2023 · AI
Understanding human neutralizing antibodies to hepatitis C virus
$556,005Mansun Law · Scripps Research Institute, The · R01 · FY2016 · AI
Understanding human neutralizing antibodies to hepatitis C virus
$556,005Mansun Law · Scripps Research Institute, The · R01 · FY2017 · AI